Adaptogenics Health Corp. Signs Letter of Intent with Pulmonem Inc. for Proposed Reverse Takeover Transaction

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2024) - Adaptogenics Health Corp. (CSE: ADPT) ("Adaptogenics", the "Company" or the "Issuer") is pleased to announce it has entered into a non-binding letter of intent (the "LOI"), dated November 7, 2024, to acquire all of the issued and outstanding shares of Pulmonem Inc. (the "Target"), which is arm's length to the Company, resulting in a proposed reverse takeover of the Issuer (the "Transaction"). On closing of the Transaction (the...

2024-11-08 3:02 PM EST